Product Images Extraneal
View Photos of Packaging, Labels & Appearance
- Extraneal DHCP Letter 4 - iamge 04
- Extraneal DHCP Letter 1 - image 01
- Extraneal DHCP Letter 2 - image 02
- Extraneal DHCP Letter 3 - image 03
- Extraneal DHCP Letter 5 - image 05
- Extraneal DHCP Letter 6 - image 06
- Extraneal DHCP Letter 7 - image 07
- Extraneal DHCP Letter 8 - image 08
- Representative Extraneal Container Label -FPB5268C.jpg - image 09
- Representative Extraneal Carton Label - FPB5268C - image 10
- Vantive Representative Extraneal Container Label - FPB5268C - image 11
- Vantive Representative Extraneal Carton Label - FPB5268C - image 12
- Representative Extraneal Container Label - FPB5270 - image 13
- Representative Extraneal Carton Label - FPB5270 - image 14
- Vantive Representative Extraneal Container Label - FPB5270 - image 15
- Vantive Representative Extraneal Carton Label - FPB5270 - image 16
Product Label Images
The following 16 images provide visual information about the product associated with Extraneal NDC 0941-0717 by Vantive Us Healthcare Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Extraneal DHCP Letter 4 - iamge 04

This text provides detailed information about EXTRANEAL, a solution for Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD). It includes details on the composition, container type, indications, active ingredients, electrolyte content, recommended storage conditions, and expiration date. The product is intended for use in managing kidney failure patients requiring long dwell times during dialysis therapy.*
Extraneal DHCP Letter 1 - image 01

This text provides important information about the temporary importation of EXTRANEAL (icodextrin) Peritoneal Dialysis Solution from Ireland for addressing drug shortages in the United States. Baxter Healthcare Corporation is coordinating with the FDA to import this product from Ireland due to the shortage. It emphasizes that there are no clinically relevant differences between the European-manufactured and U.S.-manufactured versions of the product in terms of drug composition. Healthcare professionals are advised to refer to the FDA-approved prescribing information for details on usage, administration, and dosage of EXTRANEAL.*
Extraneal DHCP Letter 2 - image 02

This text provides detailed information about the differences between EXTRANEAL products manufactured in the EU and the US for peritoneal dialysis. It highlights differences in electrolyte concentrations, labeling, packaging, and barcoding. Healthcare providers are advised to be aware of these variances and follow alternative procedures to ensure the correct product is used. Adverse events related to the imported product can be reported to Baxter or the FDA's MedWatch Adverse Event Reporting program. Contact information for medical inquiries or placing orders is also provided.*
Extraneal DHCP Letter 3 - image 03

This text provides contact information for Dr. Geovana Basso, the Director of Americas Medical Affairs at Baxter Healthcare Corporation in Deerfield, Illinois. It also mentions the registered trademarks of Baxter International Inc, including Baxter, EXTRANEAL, and ULTRABAG (or UltraBag). Additionally, it references attached product comparison tables 1 and 2.*
Extraneal DHCP Letter 5 - image 05

A comparison of labels for EXTRANEAL (icodextrin) PD Solution Container from both Baxter and Vanive-branded labels is shown in the provided text. The labels showcase information such as the solution for peritoneal dialysis, container volume, ingredients, and storage instructions. This comparison captures the transition with imported lot labeling scenarios for these brands.*
Extraneal DHCP Letter 6 - image 06

The text appears to be a list of products or solutions related to healthcare. It mentions a product named "EXTRANEAL Solution for Peritoneal Dialysis" and includes some codes and percentages. It also references a version of "VANTIVE." This text seems to be related to medical products or solutions for dialysis.*
Extraneal DHCP Letter 8 - image 08

This is a product description for Baxter's Extraneal Solution for Peritoneal Dialysis, which contains 1000 ml. The product is approved for peritoneal dialysis use.*
Representative Extraneal Container Label -FPB5268C.jpg - image 09

This is a description of EXTRANEAL Solution for Peritoneal Dialysis manufactured by Baxter Healthcare. The solution contains various components such as Icodextrin, Sodium Chioride, Sodium (5)-lactate, Calcium Chloride, Magnesium Chloride, and is adjusted for pH using Hydrochloric acid or sodium hydroxide. It is meant for intraperitoneal use only and not for intravenous use. The solution should be used as directed by a physician, and the package leaflet should be read before use. The solution is nonpyrogenic and should not be stored below 4°C. It should only be used if the solution is clear and the container is undamaged. The product is for single use only, and any unused solution should be discarded. The manufacturing addresses are provided for the UK, Ireland, Malta, and the Netherlands.*
Representative Extraneal Carton Label - FPB5268C - image 10

This text appears to provide information about a solution for Peritoneal Dialysis called EXTRANEAL. The solution comes in a Twin bag with a Luer connector. It is intended for intraperitoneal use and should not be infused intravenously. The text also includes contact information for Baxter Healthcare Limited in the United Kingdom and Baxter Holding B.V. in the Netherlands. Additionally, it mentions instructions for storage and a warning to keep the product out of the sight and reach of children.*
Vantive Representative Extraneal Container Label - FPB5268C - image 11

The text appears to be a detailed description of EXTRANEAL Solution for Peritoneal Dialysis. It includes information about the composition of the solution, its intended use, storage instructions, and contact details of Vantive Limited. The solution is meant for intraperitoneal use under the direction of a physician and should be used as a single dose only. It emphasizes the importance of checking the solution's clarity and container integrity before use. The solution should be discarded if unused and not stored below 4°C. More specific details can be found in the package leaflet provided.*
Vantive Representative Extraneal Carton Label - FPB5268C - image 12

This is a description of Extranal FPB5268C, a solution for Peritoneal Dialysis in a 2000 ml bag with Luer connector for intraperitoneal use. The solution contains Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride, and Water. It is not for intravenous infusion and should be kept out of reach of children. The recommended storage temperature is above 4°C. Produced by Vantive Limited in the United Kingdom.*
Representative Extraneal Container Label - FPB5270 - image 13

This is a detailed description of a medical solution for Peritoneal Dialysis. It includes information on the formula, ingredients, osmolarity, pH adjustment, proper use, storage instructions, and manufacturer details. The solution is for intraperitoneal use only and should not be stored below 4°C. It is recommended to read the package leaflet before use and to keep it out of the reach of children. The solution is nonpyrogenic and for single-use only. Additionally, the instructions advise discarding any unused solution. The manufacturing details provided are Baxter Healthcare Ltd in the United Kingdom and Baxter Holding B.V in the Netherlands.*
Representative Extraneal Carton Label - FPB5270 - image 14

The text is related to a solution for peritoneal dialysis called EXTRANEAL. It comes in 2500 ml x 4 bags with a Luer connector. It includes sodium hydroxide or lactic acid for pH adjustment. The solution is for intraperitoneal use only, not for intravenous infusion, and should be kept out of the reach of children. It should not be stored below 4°C. Manufacturer details include Baxer Healthcare Limited in the UK and Baxter Holding B.V. in the Netherlands. The solution is compliant with certain standards and regulations as indicated by codes such as MA 1277/01101 and PL 0011610266.*
Vantive Representative Extraneal Container Label - FPB5270 - image 15

This is a description of "EXTRANEAL Solution for Peritoneal Dialysis" by Wantive Limited, based in the United Kingdom. The solution contains various ingredients such as Icodextrin, Sodium Chloride, Calcium Chloride, and Magnesium Chloride among others. It is intended for intraperitoneal use and should not be used intravenously. The solution is nonpyrogenic and must not be stored below 4°C. It is essential to follow the instructions provided by a physician and to read the package leaflet before use. The company contact information is given for queries or concerns.*
Vantive Representative Extraneal Carton Label - FPB5270 - image 16

This text describes a solution for peritoneal dialysis called EXTRANEAL FPB5270. It contains icodextrin, sodium chloride, calcium chloride, and water for injections. The solution is intended for intraperitoneal use in the UK only and should not be stored below 4°C. It comes in a twin bag with a Luer connector. Instructions state that it is not for intravenous infusion and should be kept out of the sight and reach of children. The product is produced by Vantive Limited in the United Kingdom.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.